fashion -WSS

fashion

author：explore 2025-09-27 21:14:42 - browse：1275

Alnylam headquarters — Kristoffer Tripplaar/Sipa USA/AP

Alnylam Pharmaceuticals said Thursday that sales of its treatments for rare diseases grew 43% in the second quarter compared to the year-ago period, as the biotech prepares for a key meeting with the Food and Drug Administration in September.

Net product sales in the quarter were $306 million, led by Amvuttra, the company’s RNAi treatment for hereditary ATTR, with sales of $132 million, exceeding Wall Street forecasts. Sales of Onpattro, its older medicine for hereditary ATTR, were $91 million, slightly less than expectations.

The FDA has scheduled a meeting of outside experts on Sept. 13 to discuss the company’s application to expand the indication for Onpattro to include ATTR-CM, a related condition that affects the heart. The FDA decision is due by Oct. 8. An expansion would open a much larger market for the drug than its current approval, which largely targets nerve-related damage.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： ADA: All diabetes patients should be screened for liver condition

focus

WSS

GOP inquiry over gain

Maui's cultural, historic landmarks damaged in the devastating wildfires

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

Maui's cultural, historic landmarks damaged in the devastating wildfires

Supreme Court rules employers must be more accommodating of religious observance

Police still searching for prisoner who escaped from NYC hospital

knowledge

fashion

knowledge

The cancer drug shortage isn’t new — and neither are the solutions

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

Medicare proposal to cover medical devices draws a mixed reaction

Methadone doses haven’t kept up in the age of fentanyl

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

ADA: All diabetes patients should be screened for liver condition

BioMarin wins approval for gene therapy to treat hemophilia A

UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

Hollywood unions extend contract negotiations for actors

FDA panel issues narrow recommendation for Covid vaccine booster doses

entertainment

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

What to know about Virgin Galactic's 1st mission taking paying customers to space

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Friends ask where James Watson's attitudes about race came from

How to use technology to prevent future drug shortages

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

focus

leisure time

focus

hotspot